CMPX
Compass Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.19
+0.00 +0.00%
🌙 3월 13일 7:31 PM ET (한국 3/14 08:31)
$5.19
+0.00 +0.05%
| Index | RUT | P/E | - | EPS (ttm) | -0.43 | Insider Own | 29.92% | Shs Outstand | 0.18B | Perf Week | -5.81% |
| Market Cap | 0.93B | Forward P/E | - | EPS next Y | -5.17% | Insider Trans | - | Shs Float | 0.13B | Perf Month | -19.41% |
| Enterprise Value | 0.74B | PEG | - | EPS next Q | -0.1 | Inst Own | 65.97% | Short Float | 18.23% | Perf Quarter | -1.14% |
| Income | -0.07B | P/S | - | EPS this Y | 4.16% | Inst Trans | 13.26% | Short Ratio | 10.35 | Perf Half Y | 47.03% |
| Sales | 0.00B | P/B | 4.7 | EPS next 5Y | 48.08% | ROA | -36.68% | Short Interest | 23.01M | Perf YTD | -3.35% |
| Book/sh | 1.1 | P/C | 4.47 | EPS past 3/5Y | -4.18% 5.72% | ROE | -41.29% | 52W High | -24.56% ($6.88) | Perf Year | 110.12% |
| Cash/sh | 1.16 | P/FCF | - | Sales past 3/5Y | - | ROIC | -32.34% | 52W Low | 290.23% ($1.33) | Perf 3Y | 48.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -20.71% | Gross Margin | - | Volatility(W/M) | 5.79% 5.66% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.34 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 15.02 | EPS Q/Q | 22.02% | Profit Margin | - | RSI (14) | 34.13 | Recom | 1.06 |
| Dividend Gr. 3/5Y | - | Current Ratio | 15.02 | Sales Q/Q | - | SMA20 | -10.37% ($5.79) | Beta | 1.31 | Target Price | $13.64 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 3000000 | SMA50 | -11.72% ($5.88) | Rel Volume | 0.48 | Prev Close | $5.19 |
| Employees | 39 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 4.26% - | SMA200 | 23.4% ($4.21) | Avg Volume(3M) | 2.22M | Price | $5.19 |
| IPO | 2021/4/5 | Option/Short | Yes/Yes | Trades | 9505 | Volume | 1,058,600 | Change | - |
뉴스 로딩 중...